Role of cytokines (TNF-alpha, IL-1 beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide


Autoria(s): MELO, Maria Luisa P.; BRITO, Gerly A. C.; SOARES, Rudy C.; CARVALHO, Sarah B. L. M.; SILVA, Johan V.; SOARES, Pedro M. G.; VALE, Mariana L.; SOUZA, Marcellus H. L. P.; CUNHA, Fernando Q.; RIBEIRO, Ronaldo A.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2008

Resumo

Introduction Irinotecan (CPT-11) is an inhibitor of DNA topoisomerase I and is clinically effective against several cancers. A major toxic effect of CPT-11 is delayed diarrhea; however, the exact mechanism by which the drug induces diarrhea has not been established. Purpose Elucidate the mechanisms of induction of delayed diarrhea and determine the effects of the cytokine production inhibitor pentoxifylline (PTX) and thalidomide (TLD) in the experimental model of intestinal mucositis, induced by CPT-11. Materials and methods Intestinal mucositis was induced in male Swiss mice by intraperitoneal administration of CPT-11 (75 mg/kg) daily for 4 days. Animals received subcutaneous PTX (1.7, 5 and 15 mg/kg) or TLD (15, 30, 60 mg/kg) or 0.5 ml of saline daily for 5 and 7 days, starting 1 day before the first CPT-11 injection. The incidence of delayed diarrhea was monitored by scores and the animals were sacrificed on the 5th and 7th experimental day for histological analysis, immunohistochemistry for TNF-alpha and assay of myeloperoxidase (MPO) activity, tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta) and KC ELISA. Results CPT-11 caused significant diarrhea, histopathological alterations (inflammatory cell infiltration, loss of crypt architecture and villus shortening) and increased intestinal tissue MPO activity, TNF-alpha, IL-1 beta and KC level and TNF-alpha immuno-staining. PTX inhibited delayed diarrhea of mice submitted to intestinal mucositis and reduced histopathological damage, intestinal MPO activity, tissue level of TNF-alpha, IL-1 beta and KC and TNF-alpha immuno-staining. TLD significantly reduced the lesions induced by CPT-11 in intestinal mucosa, decreased MPO activity, TNF-alpha tissue level and TNF-alpha immuno-staining, but did not reduce the severity of diarrhea. Conclusion These results suggest an important role of TNF-alpha, IL-1 beta and KC in the pathogenesis of intestinal mucositis induced by CPT-11.

Identificador

CANCER CHEMOTHERAPY AND PHARMACOLOGY, v.61, n.5, p.775-784, 2008

0344-5704

http://producao.usp.br/handle/BDPI/24252

10.1007/s00280-007-0534-4

http://dx.doi.org/10.1007/s00280-007-0534-4

Idioma(s)

eng

Publicador

SPRINGER

Relação

Cancer Chemotherapy and Pharmacology

Direitos

restrictedAccess

Copyright SPRINGER

Palavras-Chave #CPT-11 #mucositis #intestine #pentoxifylline #thalidomide #cytokine #NECROSIS-FACTOR-ALPHA #TRANSPLANT-RELATED TOXICITIES #NEUTROPHIL MIGRATION #PHOSPHODIESTERASE INHIBITOR #COADMINISTERED THALIDOMIDE #REDUCED TOXICITY #BREAST-CANCER #PHASE-I #IRINOTECAN #INFLAMMATION #Oncology #Pharmacology & Pharmacy
Tipo

article

original article

publishedVersion